Michael Nettersheim joined BASF Venture Capital in August 2011. Prior to joining BASF Michael served as a Senior Investment Manager at Europe’s largest seed fund HGTF (Germany). Prior to this he held the position as a Director Corporate Finance and Investor Relations at a MediGene AG, a publicly listed biotech company in Germany. He is a former Director of the Board at NanoH2O (US), and currently serves on the Board of DataLase (UK).

Michael studied Chemistry and was awarded a doctorate in Biochemistry from the University of Bonn. He holds an MBA from the Kellogg-WHU Executive MBA Program. He is also a Certified Biotech Analyst for the German Association of Financial Analysis and Asset Management (DVFA).